Financial insights of TMDX

MyFinsight

For the quarter ending 2025-09-30, TMDX made $143,823K in revenue. $24,319K in net income. Net profit margin of 16.91%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenue	143,823	157,370	143,537	108,761
Product	18,687	19,421	-	-
Service	40,561	41,360	-	-
Total cost of revenue	59,248	60,781	55,309	47,916
Gross profit	84,575	96,589	88,228	60,845
Research, development and clinical trials	15,260	15,934	17,160	14,266
Selling, general and administrative	46,015	44,088	43,625	42,656
Total operating expenses	61,275	60,022	60,785	56,922
Income from operations	23,300	36,567	27,443	3,923
Interest expense	3,491	3,476	3,461	3,617
Interest income and other income (expense)	3,222	3,091	2,694	3,939
Total other income (expense), net	-269	-385	-767	322
Income before income taxes	23,031	36,182	26,676	4,245
Current income tax expense (benefit)	-	-	-	29
(provision) benefit for income taxes	-1,288	1,275	994	-
Net income	24,319	34,907	25,682	4,216

Earnings per share, basic, total	0.71	1.03	0.76	0.13
Earnings per share, diluted, total	0.66	0.92	0.7	0.12
Weighted average common shares outstanding, diluted	40,748,023	40,558,953	39,914,487	35,683,952
Weighted average number of shares outstanding, basic, total	34,112,452	33,912,669	33,721,603	33,441,394